Thrivent Financial Boosts Arcus Biosciences Stake
Thrivent Financial for Lutherans increased its stock holdings in Arcus Biosciences (RCUS) as of late May 2026.
May 27, 2026
1 min read
46 views
Source: americanbankingnews.com
Image: americanbankingnews.com
Thrivent Financial for Lutherans has increased its stock position in Arcus Biosciences, Inc. (NYSE: RCUS), according to a recent SEC filing. The investment firm now holds a larger stake in the clinical-stage biopharmaceutical company, which focuses on developing cancer immunotherapies.
The exact number of shares and the value of the increased position were not disclosed in public filings as of May 27, 2026. Arcus Biosciences is based in Hayward, California, and is known for its work on therapies targeting the tumor microenvironment.
This move reflects Thrivent's ongoing investment strategy in the healthcare sector. Arcus Biosciences' stock has been volatile in 2026, with recent developments in its drug pipeline influencing investor sentiment.
❓ Frequently Asked Questions
What is Thrivent Financial for Lutherans?
Thrivent Financial is a Fortune 500 financial services organization that provides insurance, investments, and banking products, primarily serving Christians.
What does Arcus Biosciences do?
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies.
Why did Thrivent increase its stake in Arcus?
The specific reason was not disclosed, but it likely reflects Thrivent's investment strategy in the healthcare sector and confidence in Arcus's pipeline.
